                         SEQUENCE LISTING

<110>  BioNTech RNA Pharmaceuticals GmbH et al.
 
<120>  Treatment involving non-immunogenic RNA for antigen vaccination

<130>  674-312 PCT2

<150>  PCT/EP2020/059170
<151>  2020-03-31

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Epitope

<400>  1

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210>  2
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Epitope

<400>  2

Ile Ser Gln Ala Val His Ala Ala His Ala Glu Ile Asn Glu Ala Gly 
1               5                   10                  15      


Arg 
    


<210>  3
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GS Linker

<400>  3

Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly 
1               5                   10                  15      


Gly Ser Gly Gly 
            20  


<210>  4
<211>  190
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Interferon

<400>  4

Met Gly Ala Met Ala Pro Arg Thr Leu Leu Leu Leu Leu Ala Ala Ala 
1               5                   10                  15      


Leu Ala Pro Thr Gln Thr Arg Ala Gly Pro Gly Ser Cys Asp Leu Pro 
            20                  25                  30          


His Thr Tyr Asn Leu Gly Asn Lys Arg Ala Leu Thr Val Leu Glu Glu 
        35                  40                  45              


Met Arg Arg Leu Pro Pro Leu Ser Cys Leu Lys Asp Arg Lys Asp Phe 
    50                  55                  60                  


Gly Phe Pro Leu Glu Lys Val Asp Asn Gln Gln Ile Gln Lys Ala Gln 
65                  70                  75                  80  


Ala Ile Leu Val Leu Arg Asp Leu Thr Gln Gln Ile Leu Asn Leu Phe 
                85                  90                  95      


Thr Ser Lys Asp Leu Ser Ala Thr Trp Asn Ala Thr Leu Leu Asp Ser 
            100                 105                 110         


Phe Cys Asn Asp Leu His Gln Gln Leu Asn Asp Leu Lys Ala Cys Val 
        115                 120                 125             


Met Gln Glu Pro Pro Leu Thr Gln Glu Asp Ser Leu Leu Ala Val Arg 
    130                 135                 140                 


Thr Tyr Phe His Arg Ile Thr Val Tyr Leu Arg Lys Lys Lys His Ser 
145                 150                 155                 160 


Leu Cys Ala Trp Glu Val Ile Arg Ala Glu Val Trp Arg Ala Leu Ser 
                165                 170                 175     


Ser Ser Thr Asn Leu Leu Ala Arg Leu Ser Glu Glu Lys Glu 
            180                 185                 190 


